BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20861762)

  • 1. Distinguishing clear cell renal cell carcinoma, retroperitoneal paraganglioma, and adrenal cortical lesions on limited biopsy material: utility of immunohistochemical markers.
    Lapinski JE; Chen L; Zhou M
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):414-21. PubMed ID: 20861762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray.
    He H; Zhou GX; Zhou M; Chen L
    Int J Gynecol Pathol; 2011 Sep; 30(5):425-30. PubMed ID: 21804394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases.
    Sangoi AR; Fujiwara M; West RB; Montgomery KD; Bonventre JV; Higgins JP; Rouse RV; Gokden N; McKenney JK
    Am J Surg Pathol; 2011 May; 35(5):678-86. PubMed ID: 21490444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspiration biopsy of osseous metastasis of retroperitoneal paraganglioma. Report of a case with cytologic features and differential diagnostic considerations.
    Absher KJ; Witte DA; Truong LD; Ramzy I; Mody DR; Ostrowski ML
    Acta Cytol; 2001; 45(2):249-53. PubMed ID: 11284313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma.
    Browning L; Bailey D; Parker A
    J Clin Pathol; 2008 Mar; 61(3):293-6. PubMed ID: 17660332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.
    Weinbreck N; Marie B; Bressenot A; Montagne K; Joud A; Baumann C; Klein O; Vignaud JM
    Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD10 facilitates the diagnosis of metastatic renal cell carcinoma from primary adrenal cortical neoplasm in adrenal fine-needle aspiration.
    Yang B; Ali SZ; Rosenthal DL
    Diagn Cytopathol; 2002 Sep; 27(3):149-52. PubMed ID: 12203861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.
    Fetsch PA; Powers CN; Zakowski MF; Abati A
    Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC; Chen PC; Ho DM
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.
    Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG
    Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical features of paragangliomas.
    Pávai Z; Orosz Z; Horváth E; Seres-Sturm L; Jung J
    J Cell Mol Med; 2001; 5(3):311-6. PubMed ID: 12067490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of immunohistochemical markers in the differential diagnosis of adrenocortical tumors: immunohistochemical analysis of adrenocortical tumors.
    Zhang H; Bu H; Chen H; Wei B; Liu W; Guo J; Li F; Liao D; Tang Y; Zhang Z
    Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):32-9. PubMed ID: 18091323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
    Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
    Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-needle aspiration of metastatic clear cell carcinoma of the kidney: employment of microdissection and the polymerase chain reaction as a potential diagnostic tool.
    Beaty MW; Zhuang Z; Park WS; Emmert-Buck MR; Linehan WM; Lubensky IA; Abati A
    Cancer; 1997 Jun; 81(3):180-6. PubMed ID: 9196017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms.
    Zhou M; Roma A; Magi-Galluzzi C
    Clin Lab Med; 2005 Jun; 25(2):247-57. PubMed ID: 15848735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonfunctional retroperitoneal paraganglioma presenting as acute upper gastrointestinal hemorrhage.
    Brankovic B; Radisavljevic M; Radojkovic M; Stanojevic G; Stojanovic M; Nagorni A; Radojkovic D; Jeremic L; Nestorovic M; Karamarkovic A
    Hepatogastroenterology; 2010; 57(98):288-91. PubMed ID: 20583429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomorphologic spectrum in paraganglioma.
    Varma K; Jain S; Mandal S
    Acta Cytol; 2008; 52(5):549-56. PubMed ID: 18833816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.